惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

小众软件
小众软件
博客园 - Franky
罗磊的独立博客
G
Google Developers Blog
The GitHub Blog
The GitHub Blog
P
Proofpoint News Feed
Recent Announcements
Recent Announcements
V
V2EX
F
Fortinet All Blogs
阮一峰的网络日志
阮一峰的网络日志
Blog — PlanetScale
Blog — PlanetScale
月光博客
月光博客
U
Unit 42
GbyAI
GbyAI
A
About on SuperTechFans
WordPress大学
WordPress大学
Engineering at Meta
Engineering at Meta
雷峰网
雷峰网
Microsoft Azure Blog
Microsoft Azure Blog
Martin Fowler
Martin Fowler
D
DataBreaches.Net
The Cloudflare Blog
H
Hackread – Cybersecurity News, Data Breaches, AI and More
MongoDB | Blog
MongoDB | Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Loews: Risk Confirmed In 1Q26
Wolf Report · 2026-05-05 · via All Articles on Seeking Alpha

Summary

  • Loews remains a "Hold," with a raised price target of $84/share, reflecting persistent overvaluation and heightened risk in its core insurance subsidiary CNA.
  • CNA's deteriorating underwriting, evidenced by a combined ratio above 102%, signals structural challenges and justifies a continued valuation discount for L.
  • Despite solid performance in non-insurance segments, L's low yield (<0.25%) and reliance on buybacks limit total return appeal versus peers.
  • The Loews discount is warranted given muted growth, weak dividend policy, and historical underperformance relative to market benchmarks.
  • I do much more than just articles at Wolf of Value: Members get access to model portfolios, regular updates, a chat room, and more. Learn More »
A Loews Hotel in Chicago, Illinois, USA.

JHVEPhoto/iStock Editorial via Getty Images

Loews (L) is one of those companies that I have covered for some time. My latest coverage on the company can be found here, and in this coverage, I reiterate a "Hold" rating. The company has, based on my targets, at certain times, been an attractive investment. Unfortunately, that time

35.26K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice. It may be structured as such, but it is not financial advice. Investors are required and expected to do their own due diligence and research prior to any investment. Short-term trading, options trading/investment and futures trading are potentially extremely risky investment styles. They generally are not appropriate for someone with limited capital, limited investment experience, or a lack of understanding for the necessary risk tolerance involved. I own the European/Scandinavian tickers (not the ADRs) of all European/Scandinavian companies listed in my articles. I own the Canadian tickers of all Canadian stocks I write about. Please note that investing in European/Non-US stocks comes with withholding tax risks specific to the company's domicile as well as your personal situation. Investors should always consult a tax professional as to the overall impact of dividend withholding taxes and ways to mitigate these.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.